Condition: Prostate Cancer · Sponsor: University of Texas Southwestern Medical Center
This is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveillance.
This description comes directly from the study's public registry record.
Catherine Robinson · 214-645-8103 · Catherine.Robinson@utsouthwestern.edu
Maricruz Ibarra · 214-645-8788 · maricruz.ibarra@utsouthwestern.edu
Always discuss trial participation with your own doctor first.
| UT Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03769766